- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00207584
Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting
September 13, 2005 updated by: Centers for Disease Control and Prevention
A Double-Blind, Randomized Placebo-Controlled Trial of Doxycycline for Chemoprophylaxis in the Setting of an Outbreak of Mycoplasma Pneumoniae
This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak.
Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Working at hospital facility where outbreak of Mycoplasma pneumoniae occured
Exclusion Criteria:
- Pregnant, on antiseizure medications, allergic to macrolide antibiotics
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Julia A Schillinger, MD, Centers for Disease Control and Prevention
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 1994
Study Completion
April 1, 1994
Study Registration Dates
First Submitted
September 13, 2005
First Submitted That Met QC Criteria
September 13, 2005
First Posted (Estimate)
September 21, 2005
Study Record Updates
Last Update Posted (Estimate)
September 21, 2005
Last Update Submitted That Met QC Criteria
September 13, 2005
Last Verified
September 1, 2005
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Infections
- Respiratory Tract Infections
- Respiratory Tract Diseases
- Lung Diseases
- Pleural Diseases
- Gram-Negative Bacterial Infections
- Bacterial Infections
- Bacterial Infections and Mycoses
- Pneumonia, Bacterial
- Pleurisy
- Mycoplasmatales Infections
- Pneumonia
- Pleuropneumonia
- Mycoplasma Infections
- Pneumonia, Mycoplasma
- Anti-Infective Agents
- Anti-Bacterial Agents
- Antiprotozoal Agents
- Antiparasitic Agents
- Antimalarials
- Doxycycline
Other Study ID Numbers
- CDC-NCHSTP-9997
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mycoplasma Pneumoniae
-
Beijing Children's HospitalShengjing Hospital; Shanxi Provincial Maternity and Children's Hospital; Baoding... and other collaboratorsCompletedMycoplasma Pneumoniae PneumoniaChina
-
Chongqing Medical UniversityTerminatedRefractory Mycoplasma Pneumoniae Pneumonia
-
Christoph BergerNot yet recruitingCommunity Acquired Pneumonia in Children | Mycoplasma Pneumoniae | Mycoplasma Pneumoniae PneumoniaSwitzerland
-
University Children's Hospital, ZurichUniversity Children's Hospital Basel; Ostschweizer KinderspitalUnknownCommunity-acquired PneumoniaSwitzerland
-
Capital Medical UniversityCompleted
-
Meridian Bioscience, Inc.Completed
-
University of PittsburghCompletedStreptococcus Pneumonia | Mycoplasma Pneumonia | Haemophilus Influencae | Chlamydia PneumoniaUnited States
-
National Taiwan University HospitalRecruiting
-
National Taiwan University HospitalRecruiting
-
Seoul National University HospitalUnknownMycoplasma Pneumoniae PneumoniaKorea, Republic of
Clinical Trials on Doxycycline treatment
-
Aljazeera HospitalUnknown
-
Medical Corps, Israel Defense ForceCompletedJarisch Herxheimer Reaction | Relapsing Fever, Tick-BorneIsrael
-
National Institute of Allergy and Infectious Diseases...Completed
-
University Hospital, BordeauxUSC EA 3671 Infections humaines à mycoplasmes et à chlamydiaeUnknownChlamydia Trachomatis Infection | Vaginal Infection | Anal InfectionFrance
-
Massachusetts General HospitalNanoSHIFT LLCRecruiting
-
Russian Academy of Medical SciencesUnknownCardiovascular Diseases | Vascular Diseases | Acute Myocardial InfarctionRussian Federation
-
UMC UtrechtAZ-VUBTerminatedMinor Intra-uterine AbnormalitiesNetherlands
-
Thomas GardnerJuvenile Diabetes Research FoundationCompleted
-
University of PittsburghTu Du HospitalCompleted
-
Warner ChilcottCompletedAcne VulgarisUnited States